A detailed history of Orbimed Advisors LLC transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,045,261 shares of ONTX stock, worth $616,703. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,045,261
Holding current value
$616,703
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.57 - $1.0 $595,798 - $1.05 Million
1,045,261 New
1,045,261 $616,000

Others Institutions Holding ONTX

About Onconova Therapeutics, Inc.


  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.